Since embelin induced apoptosis in pancreatic cancer cells harboring Kras mutation by suppressing Akt pathway, suggesting its clinical benefits against human pancreatic cancer where Kras is mostly mutated. Here, KRAS is linked to pancreatic neoplasm.